Stocksigma LogoStocksigma Logo

Onyx Biotec Independent Directors Review Open Offer for 26% Equity Stake

The Committee of Independent Directors of Onyx Biotec Limited met on 7th Oct'26 to review the open offer launched by Kunal Bhardwaj, Gautam Bhardwaj

Onyx Biotec Independent Directors Review Open Offer for 26% Equity Stake

Onyx Biotec Ltd 路 Others (Uncategorized) 路 08 Oct 2026, 12:09 am

Onyx Biotec Independent Directors Review Open Offer for 26% Equity Stake The Committee of Independent Directors of Onyx Biotec Limited met on 7th Oct'26 to review the open offer launched by Kunal Bhardwaj, Gautam Bhardwaj, Kanhaiya Bhardwaj, and Kapil Bhardwaj. The acquirers propose to acquire up to 47,14,372 equity shares (Rs 10 face value), representing 26.00% of the company's total voting equity share capital under SEBI SAST Regulations. The committee's formal recommendations will be submitted to SEBI, NSE, and manager VC Corporate Advisors, and published in newspapers following the 31st Jul'26 Detailed Public Statement.

Original exchange filing (PDF)

More announcements from Onyx Biotec Ltd

All Onyx Biotec Ltd announcements